Directorio

Es posible que algunos contenidos no estén disponibles en español.
402 clinical trials found.
Newborn and Neonatal Conditions/Birth Defects

We are doing this study to collect information about our state-of-the-art methods to care for the bladder and kidneys of babies born with spina bifida. We want to compare the results of these methods with other hospitals around the country that are following the same guidelines to protect the bladder and kidney health of infants with spina bifida. We and the other centers following these guidelines will regularly evaluate the outcomes of this care and modify the methods accordingly.

Compensation: No
Ages: 0
Non-Oncology
Duke University Hospital
Genitourinary Cancer

We are doing this study to find out if the Vanquish Water Ablation System (VAPOR), which uses small amounts of steam to destroy cancer cells, is a safe and effective method for treating intermediate-risk prostate cancer.

Compensation: Yes
Ages: 50-110
Oncology
Duke University Hospital
Biobank / Biospecimen Collections

We are doing this study to learn how we can help and improve care for patients that have had a transplant.

Compensation: No
Ages: 18-65
Non-Oncology
Duke University Hospital
Older Adults/Aging

We are doing this study to understand the changes in swallowing muscles for peoples with and without trouble swallowing.

Compensation: No
Ages: 50-110
Non-Oncology
Duke University Hospital
Primary Brain and Spinal Cord Tumors

We are doing this study to find out the practicality of using a new program called ViSPad on an electronic tablet. We want to know if this program can help reduce anxiety for cancer patients who are having imaging scans done (for example, MRI).

Compensation: No
Ages: 18-110
Oncology
Duke University Hospital
Hematologic Malignancies and Cellular Therapy

We are doing this study to evaluate the accuracy and utility of two remote vital sign monitoring devices, called TempTraq and VitalTraq, when used by blood cancer patients receiving chimeric antigen receptor (CAR) T-cell and bispecific T-cell engager (BiTE) therapies. In the future, these remote vital sign monitoring devices may help with earlier detection and intervention of treatment side effects, including cytokine release syndrome (CRS) and infections.

Compensation: Yes
Ages: 18-110
Oncology
Duke University Hospital
Older Adults/Aging

We are doing this study is to test the effectiveness of a new virtual exercise training program created for older individuals who are living with prediabetes.

Compensation: Yes
Ages: 60-110
Non-Oncology
Duke University Hospital, Other
Lungs and Breathing

We are doing this study to find out if there is a difference in breath analysis between patients with and without rejection after lung transplantation.

Compensation: Yes
Ages: 18-110
Non-Oncology
Duke University Hospital